Camilla Natalia Oliveira Santos
Overview
Explore the profile of Camilla Natalia Oliveira Santos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Oliveira Rekowski L, Caldas G, Menezes-Silva L, Santos C, Magalhaes L, Cazzaniga R, et al.
Am J Trop Med Hyg
. 2024 Nov;
112(1):124-127.
PMID: 39499953
This report documents the first known cases of lepromatous leprosy in patients with chronic mucocutaneous candidiasis (CMC) linked to a gain-of-function mutation in the STAT1 gene. Two related patients, a...
2.
Jorge K, Braga M, Cazzaniga R, Santos C, Teixeira M, Gomes K, et al.
Int J Infect Dis
. 2024 Jan;
142:106946.
PMID: 38278287
Objectives: Mycobacterium leprae is able to infect Schwann cells leading to neural damage. Neurotrophins are involved in nervous system plasticity and impact neural integrity during diseases. Investigate the association between...
3.
Santos C, Magalhaes L, Fonseca A, Bispo A, Porto R, Alves J, et al.
Sci Rep
. 2023 Mar;
13(1):3466.
PMID: 36859461
Congenital Zika syndrome (CZS) is a cluster of malformations induced by Zika virus (ZIKV) infection and the underline mechanisms involved in its occurrence are yet not fully understood. Along with...
4.
Magalhaes L, Melo E, Damascena N, Albuquerque A, Santos C, Reboucas M, et al.
Front Cell Infect Microbiol
. 2022 Dec;
12:1045668.
PMID: 36506010
This investigation aimed to assess the effect of N-acetylcysteine (NAC) as an adjuvant treatment to alleviate visceral leishmaniasis (VL). The present work includes both blinded randomized clinical intervention and experimental...
5.
Bomfim L, Magalhaes L, Rodrigues L, Barreto A, Santos C, Dos Santos P, et al.
Front Cell Infect Microbiol
. 2022 Apr;
12:863986.
PMID: 35402286
Visceral leishmaniasis (VL) is a systemic chronic and potentially fatal disease for humans. Mechanisms related to the dysregulation of the inflammatory response may be involved in both the pathogenesis and...
6.
Franco K, Amorim F, Santos M, Rollemberg C, de Oliveira F, Franca A, et al.
Front Immunol
. 2021 Dec;
12:779534.
PMID: 34970264
This is a case series study to evaluate immunological markers associated with schistosomiasis advanced fibrosis, including 69 patients from an endemic area from the State of Sergipe and from the...
7.
Magalhaes L, Bomfim L, Santos C, Dos Santos P, Tanajura D, Lipscomb M, et al.
Parasitol Res
. 2021 Jul;
120(8):2959-2964.
PMID: 34272999
Visceral leishmaniasis is a severe disease caused by protozoan parasites that include Leishmania (L.) infantum. The disease is established when parasites subvert the immune response of the host. Notably, chemotherapy-based...
8.
Adrielle Dos Santos L, Filho P, Silva A, Santos J, Santos D, Aquino M, et al.
J Infect
. 2021 Feb;
82(3):399-406.
PMID: 33589297
Background: There is growing concern about individuals reported to suffer repeat COVID-19 disease episodes, these in a small number of cases characterised as de novo infections with distinct sequences, indicative...
9.
Reynolds C, Watber P, Santos C, Ribeiro D, Alves J, Fonseca A, et al.
Front Immunol
. 2020 Mar;
11:185.
PMID: 32132999
There is an urgent need to understand the complex relationship between cross-reactive anti-viral immunity, disease susceptibility, and severity in the face of differential exposure to related, circulating Flaviviruses. Co-exposure to...